Arshad Quadri, MD, is a Cardiothoracic Surgeon, inventor and entrepreneur and is the Executive Chairman, Chief Medical Officer, and Co-founder of Veritas Aortic Solutions. He is also the Co-founder, Executive Chairman, and Managing Director of inQB8 Medical Technologies and MonarQ, a spinout resulting from inQB8’s Transcatheter Tricuspid Valve Replacement (TTVR) project acquired by Peijia Medical in 2021.

Prior to inQB8, he was the founding inventor, Chairman, and Chief Medical Officer of CardiAQ Valve Technologies, that performed the first Transcatheter Mitral Valve Replacement (TMVR) procedure and was acquired by Edwards Lifesciences in 2015 for over $350M and became the basis for EW’s EVOQUE TTVR system. 

Prior to forming CardiAQ, Dr. Quadri was an attending cardiac surgeon at St. Francis Hospital in Hartford, CT, where he performed more than 1,500 open-heart surgeries.  While his primary interest was aortic surgery and valve replacement, he was also one the leading implanters of endovascular abdominal aortic grafts and endovascular thoracic aneurysm grafts. 

Dr. Quadri began his medical career as an Orthopedic Fellow at Berkshire Medical Center in Massachusetts and went on to become a Chief Surgical Resident.  He shifted his focus to Cardiovascular Surgery and went on to do a fellowship at Long Island Jewish Hospital in New York City, before moving on to St. Francis Hospital.

Over the course of his clinical career, Dr. Quadri has invented numerous devices and is a named inventor on over 70 pending and published patents in orthopedics, cardiovascular surgery, and interventional cardiology.

Dr. Quadri graduated from Darbhanga Medical College in India and obtained Primary Fellowship from Royal College of Surgeons in London, England.  He is a Diplomat of the American College of Surgeons and the American College of Thoracic Surgeons.  He is also a member of the American Society of Thoracic Surgery and several other major medical societies including the European Society of Thoracic Surgery.